Brian Groch

Brian, CEO of Remi Therapeutics, brings decades of experience developing and delivering innovative therapies that improve lives. He has led clinical and commercial programs at leading companies—including Merck, Novartis, Horizon, Telesta Therapeutics, and Acasti Pharma—where he helped bring over 30 treatments to patients worldwide. Brian is committed to advancing Remi’s mission to restore everyday potential for individuals affected by neurological and inflammatory conditions, while delivering long-term value for investors through science-driven, high-impact solutions.